The placebo-controlled, randomized trial will include 15,000 adults in 17 countries. Volunteers for the trial are currently being recruited in Australia.
The vaccine, developed by Sanofi Pasteur, is designed to protect at-risk individuals from C. diff infections.
More Articles on Gastroenterology:
Drs. Richard Fedorak, Haili Wang Develop Urine Test for Detection of Colonic Polyps
Study: Thalidomide as Treatment for Pediatric Crohn’s Disease
6 Statistics on GI/Endoscopy Revenue Per Case in Surgery Centers by Number of ORs
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
